Gilles Montalescot, MD

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Boehringer-Ingelheim(MODEST), Bayer(MODEST), BMS(MODEST), AstraZeneca(MODEST), Pfizer(MODEST), Medtronic(MODEST), Eli-Lilly(MODEST), Sanofi-Aventis(MODEST), Amgen (MODEST) RESEARCH/RESEARCH GRANTS: AstraZeneca(SIGNIFICANT), Sanofi-Aventis(SIGNIFICANT), Pfizer(SIGNIFICANT), BMS(SIGNIFICANT), Bayer(SIGNIFICANT)

View Full Disclosure